BCL-2 Hypermethylation Is a Potential Biomarker of Sensitivity to Antimitotic Chemotherapy in Endocrine-Resistant Breast Cancer

标题
BCL-2 Hypermethylation Is a Potential Biomarker of Sensitivity to Antimitotic Chemotherapy in Endocrine-Resistant Breast Cancer
作者
关键词
-
出版物
MOLECULAR CANCER THERAPEUTICS
Volume 12, Issue 9, Pages 1874-1885
出版商
American Association for Cancer Research (AACR)
发表日期
2013-07-17
DOI
10.1158/1535-7163.mct-13-0012

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now